Skip to main content
Log in

Bioresorbierbare Scaffolds: Thrombosen vor allem in den ersten Tagen

  • Medizin aktuell_DGK-Frühjahrstagung
  • Published:
CardioVasc Aims and scope

Eine erste Auswertung des deutsch-österreichischen GABI-Registers gibt Informationen über die Sicherheit bioresorbierbarer Scaffolds unter den Bedingungen der realen Versorgung.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Grätzel, P. Bioresorbierbare Scaffolds: Thrombosen vor allem in den ersten Tagen. CV 16, 26–27 (2016). https://doi.org/10.1007/s15027-016-0862-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15027-016-0862-6

Navigation